Large-scale testing (Phase 3)Ended earlyNCT02248116
What this trial is testing
Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type
Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 198